Cambiar Investors LLC decreased its position in Colgate-Palmolive (NYSE:CL – Free Report) by 7.4% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 9,168 shares of the company’s stock after selling 732 shares during the period. Cambiar Investors LLC’s holdings in Colgate-Palmolive were worth $833,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also made changes to their positions in CL. Union Bancaire Privee UBP SA purchased a new stake in Colgate-Palmolive in the 4th quarter valued at about $32,000. Hager Investment Management Services LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at about $36,000. Reston Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at approximately $42,000. Synergy Asset Management LLC acquired a new position in shares of Colgate-Palmolive in the 4th quarter worth approximately $49,000. Finally, Capital Performance Advisors LLP purchased a new position in shares of Colgate-Palmolive during the 3rd quarter worth approximately $53,000. Institutional investors and hedge funds own 80.41% of the company’s stock.
Colgate-Palmolive Trading Up 1.6 %
NYSE CL opened at $87.35 on Wednesday. The firm’s fifty day moving average price is $90.14 and its 200 day moving average price is $96.69. Colgate-Palmolive has a 12 month low of $82.68 and a 12 month high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26. The company has a market capitalization of $71.37 billion, a price-to-earnings ratio of 24.82, a price-to-earnings-growth ratio of 4.12 and a beta of 0.44.
Colgate-Palmolive Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.29%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 56.82%.
Analyst Ratings Changes
CL has been the topic of a number of research analyst reports. Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. UBS Group cut their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. Stifel Nicolaus lowered their target price on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. TD Cowen cut their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Finally, Raymond James reissued an “outperform” rating and set a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $101.16.
Get Our Latest Stock Analysis on CL
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- Low PE Growth Stocks: Unlocking Investment Opportunities
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- The Risks of Owning Bonds
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- What Do S&P 500 Stocks Tell Investors About the Market?
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.